1. A comparison has been made between alkaline mannitol diuresis and alkaline glucose diuresis in the treatment of salicylate poisoning during an 8 hr period.
PATIENTS A N D METHODS

Clinical
Twenty-two patients were studied, being allotted to two groups in random fashion according to the letter A or B contained in sealed envelopes, which had been shuffled. The criteria for admission to the trial were circumstantial evidence that 50 or more tablets of aspirin had been taken, but no other drugs. The patients of group B were treated by intravenous fluids containing mannitol, whilst those of group A received no mannitol. The composition of the intravenous fluids is shown in Table 1 . from a sample of capillary blood. An intravenous infusion was set up, and treatment begun according to the group allocated. The sequence of bicarbonate administration differs between groups A and B. This difference resulted from technical factors in the preparation of the infusate. The time interval between admission and the start of infusion was recorded.
A urine sample was obtained and the volume, specific gravity, and pH (by indicator paper) recorded. The urine was also tested with 'Phenistix' paper which was developed (Ames & Coy Slough, Bucks.) for the demonstration of phenylketonuria but, in the presence of salicylates, gives a purple colour. Its use in this study was an attempt to assess its reliability in the diagnosis of salicylate intoxication and to examine its value as a quantitative measure of salicylate concentration. Gastric lavage was not performed.
All patients were conscious and were given an emetic in the form of syrup of ipecacuanha (30 ml) prepared in single dosage vials. The time between its administration and emesis was noted. Gastric contents were preserved for laboratory study.
Both groups of patients were studied for a period of 8 hr during which time they received a total infusion of 10 litres of fluid. Patients who passed less than 200 ml of urine in the first 90 min were given an intravenous injection of 40 mg frusemide. In view of the infusion of over 2 litres of fluid, this volume of urine may appear small, but dehydration is a common concomitant of salicylate intoxication and a low urine output might be expected. Frusemide was also given to any patient who achieved a positive fluid balance in excess of 2-5 litres at any time during the course of the study. Hourly recordings of temperature, pulse, respiratory rate and blood pressure were made. At hourly intervals after beginning the infusion, estimates of pH, Pco,, standard bicarbonate, salicylate, urea, sodium, potassium and chloride were repeated. At 2-hourly intervals the haemoglobin, packed cell volume, white cell count, eosinophil count and serum calcium were estimated. All venous blood samples were taken without stasis.
Urine samples, from an indwelling catheter in most patients, were collected at half-hourly intervals where possible, for determination of volume, specific gravity, pH, the 'Phenistix' reaction, salicylate, sodium and potassium.
Biochemical
When determinations were not carried out immediately onvenous blood, serum was separated and stored in a refrigerator at 4".
Salicylate. Urine and serum concentrations were measured by the method of Keller (1947) . Analytical difficulties in determining the salicylate concentration in gastric washings necessitated the following analytical procedure. Gastric contents were homogenized and duplicate 10 ml samples extracted three times with ether. The ether was separated, evaporated to dryness and the extract weighed. 100 mg of accurately weighed extract were hydrolysed with 1 ml of concentrated hydrochloric acid for 3 hr in a water bath. The hydrolysate was diluted, made alkaline with sodium hydroxide and the salicylate estimated as above. All determinations are reported as free salicylate. Total absorbed salicylate (TAS). This was found by measuring the total recovered in the urine and adding to it the amount remaining in the body. The latter was calculated from the serum concentration at the end of the treatment period and the size of the salicylate space, as indicated by body weight (Cumming et al., 1964) .
Serum salicylate at zero time. The highest serum salicylate which would be achieved if the whole dose were absorbed at once, with no excretion, has been described by Done (1960) as the serum salicylate at zero time (So). It is calculated from the formula log So = log S + 0.01 5 log t which assumes an excretion rate in the untreated case such that the serum salicylate falls by 50% in 20 hr. S is the serum salicylate level (mg/lOO ml) and t the time in hours since ingestion.
A similar value has been calculated, in retrospect, by dividing the total absorbed salicylate (TAS) by the salicylate space (SS) and this has been designated S, (S, = TAS/SS).
Other analyses. pH and Pco, measurements were made on blood and urine using the Astrup microtechnique (Siggard-Andersen et al., 1960) , the standard bicarbonate being calculated. Serum urea, sodium, potassium and chloride, and urinary sodium and potassium were measured on the Technicon AutoAnalyzer. Serum calcium was determined initially by Eel titrator (Evans Electroselenium Ltd, Halstead, Essex) and later by the autoanalytic cresolphthalein complexone technique (Kessler & Wolfman, 1964 Table 2 shows the salicylate excretion and urinary flow rates of the two groups. The homogeneous character of the severity of poisoning in each group may be seen. The total urinary recovery of salicylate in the 8 hr treatment period, the urine flow rate and the serum salicylate half life show no significant difference between the two groups. Table 3 shows the effects of emesis in the twelve patients in whom sampling was possibIe. Emesis occurred on average 3.8 hr after ingestion of salicylate and 30 rnin after administration of the emetic. The mean recovery of salicylate was 37.9% of the apparent ingested dose, varying between zero and 81%. The amount recovered was in general higher in patients who were admitted shortly after ingestion.
The mean volume of urine produced by patients in group A was 6.8 litres, and in group B, 9.1 litres. These results show a significant difference (P<O.OOl) and are detailed in a table (Clinical Science Table 38/6) deposited at the Royal Society of Medicine. In addition, nine patients in group A required frusemide whereas no patient in group B received it.
Falls in serum sodium, potassium, chloride and calcium occurred in both groups (see Clinical Science Table 38/7 deposited at the Royal Society of Medicine), the major part of the change occurring within 2 hr of beginning treatment. Agreater fall in serum sodium occurred in patients treated with mannitol (17 mEq/l) than in those who were not (9 mEq/l) although there was little difference in sodium balance between the two groups, all but two patients showing a positive balance. Potassium loss was similar in the two groups but the fall in serum potassium was greater in group A (1.5 mEq/l) than in group B (0.6 mEq/l). All changes in serum electrolytes had returned to normal within 24 hr. Acid-base changes are shown in Fig. 1 (full data in Clinical Science, Table 3818 , deposited at the Royal Society of Medicine). The values of serum pH seen in group B were lower and showed less variability than in group A. The urinary pH was in excess of 7-0 in both groups.
The pH values for every subject at each hourly interval have been added and the arithmetic mean of the value found. This value is referred to as the average pH, and in no way represents the pH which would result from adding equal aliquots of the samples. The plot of the average pH against time indicates the way in which this value (which is of course a logarithm) varies with time.
Changes in haemoglobin and PCV, consistent with haemodilution, occurred during the early part of the treatment period with a subsequent tendency to remain steady or to return to normal. No consistent changes were seen in the white cell counts, and whilst the eosinophil counts were low, no clear pattern emerged during recovery.
The 'Phenistix test' on serum indicated a positive result with levels above 30 mg/100 ml and provided a rough guide to the salicylate level, but accurate quantitation was impossible. In urine testing, the intensity of the purple colour was roughly proportional to the salicylate concentration at levels above 20 mg/lOO ml but false negatives were seen, particularly in acid urine.
A summary of results is provided in Table 4 . 
DISCUSSION
It has been suggested that the infusion of mannitol intravenously might increase the rate of salicylate excretion, either by increasing urinary output or by a specific effect of mannitol (MacPherson et al., 1955; Whitten, Kesaree & Goodwin, 1964; Ghose & Joekes, 1964) .
Our results indicate that the rate of excretion is not increased by the use of mannitol, although the amount of urine produced is greater (6.8 litres in 8 hr in group A, 9.1 litres in group B). Despite this result, the use of mannitol has several advantages in that the development of a marked positive fluid balance is avoided (3.2 litres in group A compared with 0.9 litres in group B); the serum pH changes are less marked with mannitol (+Om15 units and $0.005 units respectively) as are the serum potassium changes (-1.5 and -0.6 mEq/l respectively). The use of mannitol has some disadvantages in that it may be retained in large amounts (Morgan, Bennett & Polak, 1968) . These authors describe clinical complications of pulmonary oedema and oliguria in one of their patients; we have observed no such complications, but this may be explained in part by the younger age of our patients. Serum sodium showed a greater fall in the mannitol group, but there was no significant difference between the groups in the sodium balance, which in all but two patients, was positive. We take this to mean a redistribution of electrolytes between fluid compartments.
The use of 'Phenistix' papers in the diagnosis of salicylate poisoning is of interest. Whilst we were unable to determine the serum salicylate by this means as precisely as Wilcox, Espellin & Done (1966) , the test papers have proved useful. We have found that provided more than 2 hr have elapsed since ingestion and that the urine is alkaline, then a negative 'Phenistix' test on both serum and urine makes potentially severe salicylate intoxication unlikely.
The determination of So, the serum salicylate level at zero time, according to Done's criteria is not possible either after treatment has started, or before the elapse of 4 hr since ingestion, and since many patients were seen before 4 hr, it is not surprising that the use of Done's formula should yield abnormal results. The comparison of S o with S, (Table 2) indicates how attempts to determine S o may give rise to error unless the conditions laid down by Done are observed.
Much discussion has centred around the changes in electrolyte concentration observed during treatment, particularly in respect of potassium. Such changes may be seen from two points of view: firstly the change in serum concentration, and secondly the net loss during treatment. The mean fall in serum potassium was 1.5 mEq/l in group A and 0.6 mEq/l in group B. The mean net potassium loss, however, was small, being 94 and 105 mEq/l respectively. Thus the fall in serum potassium did not reflect the amount of potassium loss and in our view the loss of 100 mEq is not serious and indeed no clinical effects were observed. Moreover, in all patients the serum potassium returned to normal within 24 hr. Administration of potassium during treatment was undertaken by Morgan & Polak (1969) but despite this, their net potassium loss was 63 mEq and the fall in serum potassium averaged 1.4 mEq/l. Since these authors used only 4 litres of infusion with added potassium the similarity in the results is striking. Savage et al. (1969) administered 230 mEq of potassium during treatment and observed a fall to 2.8 mEq/l in serum potassium (a fall of approx. 2.0 mEq/l), so that the change in serum potassium concentration was not avoided by giving potassium in the manner described by these authors. More recently Lawson et al. (1969) reported a fall of 1-2 mEq/l using forced alkaline diuresis, and noted a significantly smaller fall (0.7 mEq/l) when treatment included potassium chloride given at a rate of 40 mEq/hr for 3 hr. This figure, obtained using high rates of infusion of potassium, is similar to that observed in the present study using mannitol without potassium supplements.
A greater fall of serum sodium was observed in the mannitol group and this may be due either to mannitol retention with greater haemodilution or to a redistribution of electrolytes between the body compartments. It is of interest to note that this fall in serum concentration has been observed with both the infusion regimes and, in this respect, our results differ from those of other authors.
The mean fall in serum calcium observed, viz. 2.2 mg/100 ml in group A and 2.6 mg/100 ml in group B was unaccompanied by any clinical signs or symptoms of hypocalcaemia, and like the fall in packed cell volume, we have attributed it to haemodilution.
There appear to be three determinants of the rate of salicylate excretion, the urinary pH, the volume of urine and the serum salicylate level. Lawson et al. (1969) have induced diuresis with water and shown that a large urine volume of itself is not adequate to remove salicylate rapidly. Alkaline urine, on the other hand, produces a marked improvement in salicylate excretion (MacPherson et al., 1955; Cumming et al., 1964; Lawson et al., 1969) . What is not clear is the volume of alkaline urine necessary to maximize the clearance rate, and the relationship between urine volume and clearance rate. The evidence in this paper suggests that an increase in the volume of alkaline urine from 6.8 to 9.1 litres exerts no effect upon the rate of salicylate excretion. Morgan & Polak (1969) obtained rates of salicylate removal similar to those described in this paper using only 4 litres of fluid, and in some individual cases, less than 2 litres. The salicylate clearance obtained in our patients averages 11 mg/min, whilst Morgan & Polak quoted 13 mg/min and Lawson et al. 10.0 mg/min. The urine flows obtained by Morgan & Polak were about one-third of those described herein.
It therefore seems likely that benefit would be conferred in the treatment of salicylate poisoning by the use of smaller volumes of infusate. If this were shown to be effective, the benefits of mannitol would become equivocal, and the role of potassium would require reassessment.
Induced emesis. The experimental work of Arnold, Hodges & Barta (1959) suggested that induced emesis was the most effective method of emptying the stomach of aspirin, and that syrup of ipecacuanha was a suitable agent. Our experience has confirmed the favourable reports of other workers (Robertson, 1962; Dabbous, Bergman & Robertson, 1965; Marsh, 1966; Shirkey, 1966) . The average time between administration of ipecacuanha and emesis was 30 min and only two patients failed to vomit within the hour. The mean recovery (38%) compares favourably with values obtained by gastric lavage (Matthew et al., 1966) , a similar variability in recovery being recorded. The average time between ingestion and emesis was 3.8 hr and since substantial recoveries of salicylate were obtained at this time, absorption appears to be delayed, so that delayed treatment should not deter efforts to empty the stomach. Thus in one patient a recovery of 58% was observed 305 min after ingestion. Such cases were exceptional and, in general, high recovery rates were observed when emesis was induced soon after ingestion. No side effects or complications of using ipecacuanha were seen, and one advantage over gastric lavage lay in the smaller general upset involved for the patient, enabling intravenous infusion of alkaline mannitol solutions to be instituted and maintained during the period of emesis.
APPENDIX
The preparation and quality control of sodium chloride, sodium bicarbonate and mannitol injections These notes are prepared for the benefit of pharmacists who may be asked to make available supplies of the mannitol infusate for use in salicylate poisoning.
The freshly prepared solution is filtered and packed in 500 ml quantities in transfusion bottles. The bottles should be sealed with tightly fitting rubber plugs and under these circumstances it has been found unnecessary to saturate the solution with carbon dioxide before sterilization, which is by the British Pharmacopoeia method of 'Heating in an Autoclave'. Some samples of mannitol are pyrogenic and it is therefore most important that any material used should comply with the 'Test for Pyrogens' of the British Pharmacopoeia. Full details of quality control and preparation are available on request.
It is a pleasure to acknowledge the enthusiasm and dedication to duty of the ward sisters and their staff without whom this paper would have been impossible. The house physicians also played a no less valuable role. The Birmingham Regional Hospital Board helped greatly by arranging referral of all patients poisoned with aspirin to this hospital.
